Inhibitors of hepatitis C virus NS3/4A: α-Ketoamide based macrocyclic inhibitors

Inhibitors of hepatitis C virus NS3/4A: α-Ketoamide based macrocyclic inhibitors Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro Inhibitors of hepatitis C virus NS3·4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2–P1′ Region Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease Identification of Weak Points of Hepatitis C Virus NS3 Protease Inhibitors Using Surface Plasmon Resonance Biosensor-Based Interaction Kinetic Analysis and Genetic Variants